Intuitive Surgical, Inc. (ISRG) Position Decreased by Quotient Investors LLC

Quotient Investors LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,000 shares of the medical equipment provider’s stock after selling 100 shares during the period. Quotient Investors LLC’s holdings in Intuitive Surgical were worth $766,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in ISRG. Parkwood LLC bought a new position in Intuitive Surgical during the third quarter valued at approximately $281,000. Gateway Investment Advisers LLC increased its position in Intuitive Surgical by 4.3% in the third quarter. Gateway Investment Advisers LLC now owns 40,553 shares of the medical equipment provider’s stock valued at $29,394,000 after buying an additional 1,672 shares during the period. Insight Capital Research & Management Inc. bought a new position in Intuitive Surgical during the third quarter valued at approximately $1,230,000. Henderson Group PLC increased its position in Intuitive Surgical by 3.0% in the third quarter. Henderson Group PLC now owns 4,873 shares of the medical equipment provider’s stock valued at $3,531,000 after buying an additional 142 shares during the period. Finally, Howard Capital Management bought a new position in Intuitive Surgical during the third quarter valued at approximately $217,000. 91.16% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at 870.33 on Friday. The stock has a market cap of $32.06 billion, a PE ratio of 43.87 and a beta of 0.55. The firm’s 50-day moving average price is $814.31 and its 200 day moving average price is $716.19. Intuitive Surgical, Inc. has a 12-month low of $610.71 and a 12-month high of $874.54.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 18th. The medical equipment provider reported $5.09 EPS for the quarter, topping analysts’ consensus estimates of $3.97 by $1.12. The business had revenue of $674.20 million during the quarter, compared to the consensus estimate of $664.72 million. Intuitive Surgical had a return on equity of 14.24% and a net margin of 27.21%. The business’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same period in the prior year, the firm posted $4.42 EPS. Analysts anticipate that Intuitive Surgical, Inc. will post $23.61 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://sportsperspectives.com/2017/05/20/quotient-investors-llc-lowers-stake-in-intuitive-surgical-inc-isrg-updated-updated-updated.html.

ISRG has been the topic of several recent research reports. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price objective on the stock in a research note on Monday, April 24th. Canaccord Genuity reissued a “buy” rating and set a $800.00 target price on shares of Intuitive Surgical in a research note on Friday, March 24th. Barclays PLC reissued a “buy” rating and set a $800.00 target price on shares of Intuitive Surgical in a research note on Sunday, March 26th. Wedbush lifted their target price on Intuitive Surgical from $835.00 to $875.00 and gave the company an “outperform” rating in a research note on Monday, April 24th. Finally, Bank of America Corp set a $800.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research note on Tuesday, February 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $816.64.

In related news, VP Jamie Samath sold 4,268 shares of the company’s stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $750.00, for a total transaction of $3,201,000.00. Following the completion of the sale, the vice president now directly owns 896 shares of the company’s stock, valued at approximately $672,000. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Alan J. Levy sold 1,386 shares of the company’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $813.15, for a total transaction of $1,127,025.90. Following the sale, the director now directly owns 2,598 shares of the company’s stock, valued at $2,112,563.70. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 71,778 shares of company stock valued at $56,370,272. 3.10% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

12 Month Chart for NASDAQ:ISRG

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply